Literature DB >> 28455778

On the Role of Mining Exposure in Epigenetic Effects in Parkinson's Disease.

Sebastian Castillo1, Patricia Muñoz1, Maria Isabel Behrens1, Fernando Diaz-Grez1, Juan Segura-Aguilar2.   

Abstract

To explore the possible influence of heavy metal mining on incidence of Parkinson's disease (PD), global DNA methylation was assessed in blood samples from a population of PD patients (n = 45) and control subjects (n = 52) in Antofagasta neighborhood, a Chilean city built for exclusive use of mining companies. Comparisons were made with PD subjects (n = 52) and control subjects (n = 59) from Santiago Chile, a city having little association with mining. All subjects were assessed by two neurologists and PD diagnosis was based on UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria. From blood samples obtained from each individual, a decrease in global DNA methylation was observed in PD patients either exposed (49% of control, P < 0.001) or not exposed (47% of control, P < 0.001) to mining activity. Although there was no difference in levels of DNA methylation between PD patients from the two cities, there was a lower level of DNA methylation in control subjects from Santiago versus Antofagasta.

Entities:  

Keywords:  DNA methylation; Environmental factors; Epigenetics; Mining; Parkinson’s disease

Mesh:

Substances:

Year:  2017        PMID: 28455778     DOI: 10.1007/s12640-017-9736-7

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  9 in total

1.  Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.

Authors:  Ahmad Jowaed; Ina Schmitt; Oliver Kaut; Ullrich Wüllner
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 2.  Parkinson's disease and occupational exposures: a systematic literature review and meta-analyses.

Authors:  Lars-Gunnar Gunnarsson; Lennart Bodin
Journal:  Scand J Work Environ Health       Date:  2017-04-05       Impact factor: 5.024

Review 3.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

4.  [Parkinson disease mortality rates in Chile].

Authors:  Pedro Chaná C; Magdalena Jiménez C; Violeta Díaz T; Carlos Juri
Journal:  Rev Med Chil       Date:  2013-03       Impact factor: 0.553

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.

Authors:  Lumine Matsumoto; Hiroshi Takuma; Akira Tamaoka; Hiroshi Kurisaki; Hidetoshi Date; Shoji Tsuji; Atsushi Iwata
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

Review 7.  DNA methylation in Parkinson's disease.

Authors:  Ullrich Wüllner; Oliver Kaut; Laura deBoni; Dominik Piston; Ina Schmitt
Journal:  J Neurochem       Date:  2016-06-10       Impact factor: 5.372

Review 8.  Manganese neurotoxicity: behavioral disorders associated with dysfunctions in the basal ganglia and neurochemical transmission.

Authors:  Safa Bouabid; Anass Tinakoua; Nouria Lakhdar-Ghazal; Abdelhamid Benazzouz
Journal:  J Neurochem       Date:  2015-12-28       Impact factor: 5.372

Review 9.  The prevalence of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Tamara Pringsheim; Nathalie Jette; Alexandra Frolkis; Thomas D L Steeves
Journal:  Mov Disord       Date:  2014-06-28       Impact factor: 10.338

  9 in total
  3 in total

Review 1.  Contributions and Limitations of Mitochondria-Targeted and Non-Targeted Antioxidants in the Treatment of Parkinsonism: an Updated Review.

Authors:  Priyajit Banerjee; Ishita Saha; Diptendu Sarkar; Arpan Kumar Maiti
Journal:  Neurotox Res       Date:  2022-04-07       Impact factor: 3.911

Review 2.  Role of mitochondria DNA A10398G polymorphism on development of Parkinson's disease: A PRISMA-compliant meta-analysis.

Authors:  I-Shiang Tzeng
Journal:  J Clin Lab Anal       Date:  2022-02-11       Impact factor: 2.352

Review 3.  How are social determinants of health integrated into epigenetic research? A systematic review.

Authors:  Linnea Evans; Michal Engelman; Alex Mikulas; Kristen Malecki
Journal:  Soc Sci Med       Date:  2021-02-03       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.